Patient-Reported Outcome Measure for Meningiomas study

Recruiting

• Conditions: benign primary brain tumor; Meningioma; 10029209

• Registration Number: NL-OMON43114
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 165

Inclusion Criteria

In order to be eligible to participate in this study, a subject should:
1. be diagnosed clinically or histopathologically with a WHO grade 1 meningioma
2. be 18 years or older
3. give written informed consent prior to inclusion

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
1. Patients with a neurofibromatosis type 2 meningioma.
2. Patients not fluent in Dutch, English or Italian (depending on the country where they live).
3. Patients with physical or mental conditions interfering with the understanding and completion of questions and questionnaires.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified